A 27‐year old caucasian male was diagnosed 2.7 years after kidney transplantation with Epstein‐Barr virus (EBV)‐associated smooth muscle tumors in liver and spleen. The reduction in immunosuppression and conversion from… Click to show full abstract
A 27‐year old caucasian male was diagnosed 2.7 years after kidney transplantation with Epstein‐Barr virus (EBV)‐associated smooth muscle tumors in liver and spleen. The reduction in immunosuppression and conversion from tacrolimus to sirolimus did not lead to a regression of the tumors. Additionally, the patient developed a cellular rejection of his renal allograft, which was successfully treated. A combined approach with stereotactic radiofrequency ablation (SRFA) and surgical resection was effective in the treatment of the tumors.
               
Click one of the above tabs to view related content.